Poliovirus, Car -T, Proton Beam and seaweed

1 min read


  • Two clinical trials are underway to assess the effectiveness of a type of cell-based therapy called CAR T-cells in tackling diffuse intrinsic pontine glioma (DIPG), and another related disease with a similarly poor prognosis, diffuse midline glioma (DMG). Both trials are using the genetically engineered cells, most often made by taking a patient’s own T-cells and genetically manipulating them to hone in on a specific target present on cancer cells and attack them. When reporting on her findings leader of the clinical trial at Stanford University Michelle Monje, MD, PhD, says “It was a striking and consistent result; after more than a decade of research in DIPG preclinical models, I had never seen anything that promising.”
  • If you two minutes to spare this weekend watch this video clip about how “Gammatiles zap brain cancer” – essentially after a tumour is removed, a gamma tile is left in place to attack any newly growing cells within its vicinity.

Related reading:

If you found this story interesting or helpful, sign up to our weekly e-news and keep up to date with all the latest from Brain Tumour Research.

Back to Research & Campaigning News